Meeting
2014 ASCO Annual Meeting
A phase II study of perioperative therapy for patients with resectable and borderline-resectable pancreatic adenocarcinoma.
Authors
Andrew L. Coveler
University of Washington, Seattle, WA
Andrew L. Coveler , Venu Gopal Pillarisetty , Grace Gyurkey , Wui-Jin Koh , Melissa Upton , Carlos Cuevas , Theodore Gooley , E. Gabriela Chiorean , Veena Shankaran , William Proctor Harris , James Oh Park , Gary N. Mann , David R. Byrd , Stacey Balas , Samuel H. Whiting
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Clinical Trial Registration Number
NCT00609336
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4120)
DOI
10.1200/jco.2014.32.15_suppl.4120
Abstract #
4120
Poster Bd #
207
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2020 Gastrointestinal Cancers Symposium
Phase II study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.
First Author: Emerson Yu-sheng Chen
Poster
2018 Gastrointestinal Cancers Symposium
Ampullary adenocarcinoma: A single center experience.
First Author: Jason Henry
Poster
2017 Gastrointestinal Cancers Symposium
NESC multicenter phase II trial in the preoperative treatment of gastric adenocarcinoma with chemotherapy (docetaxel-cisplatin-5FU + lenograstim) followed by chemoradiation (RTCT) based 5FU and oxaliplatin and surgery.
First Author: Laurent Mineur